13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q4 2024 · Filed January 21, 2025 · Accession 0000950123-25-000395
Total Value
$146.3M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $65.9M | 45.01% |
| 2 | Tectonic Therapeutics, Inc. | TECX | 1,028,674 | $47.5M | 32.46% |
| 3 | Kyverna Therapeutics, Inc. | KYTX | 4,523,924 | $16.9M | 11.56% |
| 4 | Dyne Therapeutics, Inc. | DYN | 407,499 | $9.6M | 6.56% |
| 5 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $3.8M | 2.62% |
| 6 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $2.6M | 1.80% |